InMed Pharmaceuticals (OTCMKTS:IMLFF – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare InMed Pharmaceuticals to similar businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, earnings, profitability and valuation. Earnings and Valuation This table compares InMed […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 462 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare InMed Pharmaceuticals to similar businesses based on the strength of its earnings, dividends, institutional ownership, risk, valuation, profitability and analyst recommendations. Profitability This table compares InMed Pharmaceuticals and […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 347 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare InMed Pharmaceuticals to similar businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, institutional ownership and profitability. Insider & Institutional Ownership 24.7% of shares […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 365 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare InMed Pharmaceuticals to similar businesses based on the strength of its valuation, institutional ownership, analyst recommendations, dividends, risk, earnings and profitability. Profitability This table compares InMed Pharmaceuticals and […]
InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Rating)’s stock price dropped 0.8% during mid-day trading on Monday . The stock traded as low as $1.23 and last traded at $1.27. Approximately 45,993 shares were traded during mid-day trading, an increase of 305% from the average daily volume of 11,369 shares. The stock had previously closed at […]